{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:15:05Z","timestamp":1780352105833,"version":"3.54.1"},"reference-count":111,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2020,6,12]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is characterised by numerous abnormalities in B lineage cells, including increased CD27++ plasmablasts\/plasma cells, atypical CD27-IgD- B cells with increased CD95, spleen tyrosine kinase (Syk)++, CXCR5- and CXCR5+ subsets and anergic CD11c+Tbet+ age-associated B cells. Most findings, together with preclinical lupus models, support the concept of B cell hyperactivity in SLE. However, it remains largely unknown whether these specific B cell subsets have pathogenic consequences and whether they provide relevant therapeutic targets. Recent findings indicate a global distortion of B cell functional capability, in which the entire repertoire of na\u00efve and memory B cells in SLE exhibits an anergic or postactivated (APA) functional phenotype. The APA status of SLE B cells has some similarities to the functional derangement of lupus T cells. APA B cells are characterised by reduced global cytokine production, diminished B cell receptor (BCR) signalling with decreased Syk and Bruton\u2019s tyrosine kinase phosphorylation related to repeated in vivo BCR stimulation as well as hyporesponsiveness to toll-like receptor 9 engagement, but intact CD40 signalling. This APA status was related to constitutive co-localisation of CD22 linked to phosphatase SHP-1 and increased overall protein phosphatase activities. Notably, CD40 co-stimulation could revert this APA status and restore BCR signalling, downregulate protein tyrosine phosphatase transcription and promote B cell proliferation and differentiation. The APA status and their potential rescue by bystander help conveyed through CD40 stimulation not only provides insights into possible mechanisms of escape of autoreactive clones from negative selection but also into novel ways to target B cells therapeutically.<\/jats:p>","DOI":"10.1136\/rmdopen-2020-001258","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T12:35:12Z","timestamp":1594902912000},"page":"e001258","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Therapeutic implications of the anergic\/postactivated status of B cells in systemic lupus erythematosus"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6478-7725","authenticated-orcid":false,"given":"Thomas","family":"D\u00f6rner","sequence":"first","affiliation":[{"name":"Rheumatology, Charit\u00e9 Hospital, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Szelinski","sequence":"additional","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia C","family":"Lino","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9 University Hospital, Berlin, Germany"},{"name":"German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E","family":"Lipsky","sequence":"additional","affiliation":[{"name":"RILITE Research Institute, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"2025090313095507000_6.2.e001258.1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000000"},{"key":"2025090313095507000_6.2.e001258.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60954-X"},{"key":"2025090313095507000_6.2.e001258.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-003-0119-1"},{"key":"2025090313095507000_6.2.e001258.4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00306"},{"key":"2025090313095507000_6.2.e001258.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.10949"},{"key":"2025090313095507000_6.2.e001258.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096495"},{"key":"2025090313095507000_6.2.e001258.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.851"},{"key":"2025090313095507000_6.2.e001258.8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.10.5970"},{"key":"2025090313095507000_6.2.e001258.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.23498"},{"key":"2025090313095507000_6.2.e001258.10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6624"},{"key":"2025090313095507000_6.2.e001258.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204116"},{"key":"2025090313095507000_6.2.e001258.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.10445"},{"key":"2025090313095507000_6.2.e001258.13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.7.3610"},{"key":"2025090313095507000_6.2.e001258.14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"2025090313095507000_6.2.e001258.15","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3175"},{"key":"2025090313095507000_6.2.e001258.16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501209"},{"key":"2025090313095507000_6.2.e001258.17","doi-asserted-by":"publisher","DOI":"10.1038\/ni1036"},{"key":"2025090313095507000_6.2.e001258.18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060087"},{"key":"2025090313095507000_6.2.e001258.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.03.003"},{"key":"2025090313095507000_6.2.e001258.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119073"},{"key":"2025090313095507000_6.2.e001258.21","doi-asserted-by":"crossref","unstructured":"Wu XN , Ye YX , Niu JW , et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med 2014;6:246ra99 doi: 10.1126\/scitranslmed.3009131.","DOI":"10.1126\/scitranslmed.3009131"},{"key":"2025090313095507000_6.2.e001258.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006703","article-title":"Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy","volume":"4","author":"Galligan","year":"2009","journal-title":"PLoS One"},{"key":"2025090313095507000_6.2.e001258.23","doi-asserted-by":"publisher","DOI":"10.1186\/ar2528"},{"key":"2025090313095507000_6.2.e001258.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2010.06.009"},{"key":"2025090313095507000_6.2.e001258.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008"},{"key":"2025090313095507000_6.2.e001258.26","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/art.40181","article-title":"Plasmablasts with a mucosal phenotype contribute to plasmacytosis in systemic lupus erythematosus","volume":"69","author":"Mei","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.27","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201970107"},{"key":"2025090313095507000_6.2.e001258.28","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and opportunities for consistent classification of human B cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front Immunol"},{"key":"2025090313095507000_6.2.e001258.29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-015-0580-y","article-title":"CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis","volume":"17","author":"Mahmood","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2025090313095507000_6.2.e001258.30","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41467-019-10387-7","article-title":"Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases","volume":"10","author":"Rubin","year":"2019","journal-title":"Nat Commun"},{"key":"2025090313095507000_6.2.e001258.31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"2025090313095507000_6.2.e001258.32","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12339"},{"key":"2025090313095507000_6.2.e001258.33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501027"},{"key":"2025090313095507000_6.2.e001258.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-243071"},{"key":"2025090313095507000_6.2.e001258.35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"2025090313095507000_6.2.e001258.36","doi-asserted-by":"publisher","DOI":"10.1002\/art.37828"},{"key":"2025090313095507000_6.2.e001258.37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901297"},{"key":"2025090313095507000_6.2.e001258.38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1901340116"},{"key":"2025090313095507000_6.2.e001258.39","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1002\/art.38854","article-title":"Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus","volume":"66","author":"Fleischer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.40","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12795"},{"key":"2025090313095507000_6.2.e001258.41","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3389\/fimmu.2019.02136","article-title":"Identification and characterization of post-activated B cells in systemic autoimmune diseases","volume":"10","author":"Weissenberg","year":"2019","journal-title":"Front Immunol"},{"key":"2025090313095507000_6.2.e001258.42","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00739-6"},{"key":"2025090313095507000_6.2.e001258.43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcimb.2012.00128","article-title":"Diverse phosphorylation patterns of B cell receptor-associated signaling in naive and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level","volume":"2","author":"Toapanta","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090313095507000_6.2.e001258.44","doi-asserted-by":"publisher","DOI":"10.1038\/nri2172"},{"key":"2025090313095507000_6.2.e001258.45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1300"},{"key":"2025090313095507000_6.2.e001258.46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304888110"},{"key":"2025090313095507000_6.2.e001258.47","doi-asserted-by":"publisher","DOI":"10.1002\/art.37818"},{"key":"2025090313095507000_6.2.e001258.48","doi-asserted-by":"publisher","DOI":"10.1038\/ni1121"},{"key":"2025090313095507000_6.2.e001258.49","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0212095"},{"key":"2025090313095507000_6.2.e001258.50","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2439"},{"key":"2025090313095507000_6.2.e001258.51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker263"},{"key":"2025090313095507000_6.2.e001258.52","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2009.19"},{"key":"2025090313095507000_6.2.e001258.53","doi-asserted-by":"publisher","DOI":"10.1038\/ng.79"},{"key":"2025090313095507000_6.2.e001258.54","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137174"},{"key":"2025090313095507000_6.2.e001258.55","first-page":"704","article-title":"Polymorphisms in the FAM167A-BLK, but not BANK1, are associated with primary Sjogren\u2019s syndrome in a Han Chinese population","volume":"31","author":"Sun","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313095507000_6.2.e001258.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.02.002"},{"key":"2025090313095507000_6.2.e001258.57","doi-asserted-by":"publisher","DOI":"10.2310\/6650.2001.34042"},{"key":"2025090313095507000_6.2.e001258.58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.5.3272"},{"key":"2025090313095507000_6.2.e001258.59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051503"},{"key":"2025090313095507000_6.2.e001258.60","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5104"},{"key":"2025090313095507000_6.2.e001258.61","doi-asserted-by":"publisher","DOI":"10.1038\/ni892"},{"key":"2025090313095507000_6.2.e001258.62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2016.10.018","article-title":"The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans","volume":"173","author":"Dam","year":"2016","journal-title":"Clin Immunol"},{"key":"2025090313095507000_6.2.e001258.63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0713370"},{"key":"2025090313095507000_6.2.e001258.64","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/art.39559","article-title":"Enhanced tyrosine phosphatase activity underlies dysregulated B cell receptor signaling and promotes survival of human lupus B cells","volume":"68","author":"Fleischer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2019.03.003","article-title":"Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in systemic lupus erythematosus","volume":"58","author":"Vasquez","year":"2019","journal-title":"Cell Signal"},{"key":"2025090313095507000_6.2.e001258.66","doi-asserted-by":"publisher","DOI":"10.1126\/science.1213368"},{"key":"2025090313095507000_6.2.e001258.67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01637"},{"key":"2025090313095507000_6.2.e001258.68","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.39020","article-title":"Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity","volume":"67","author":"Choi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700079"},{"key":"2025090313095507000_6.2.e001258.70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-091744"},{"key":"2025090313095507000_6.2.e001258.71","doi-asserted-by":"crossref","unstructured":"Meidan E , Li H , Pan W , et al. Serine\/threonine phosphatase PP2A is essential for optimal B cell function. JCI Insight 2020;5 doi: 10.1172\/jci.insight.130655.","DOI":"10.1172\/jci.insight.130655"},{"key":"2025090313095507000_6.2.e001258.72","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.berh.2017.10.003","article-title":"Role of interferons in SLE","volume":"31","author":"Bengtsson","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090313095507000_6.2.e001258.73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3569"},{"key":"2025090313095507000_6.2.e001258.74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7397"},{"key":"2025090313095507000_6.2.e001258.75","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00323-6"},{"key":"2025090313095507000_6.2.e001258.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.05.012"},{"key":"2025090313095507000_6.2.e001258.77","first-page":"76","article-title":"Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus","volume":"35","author":"Ginsburg","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"2025090313095507000_6.2.e001258.78","doi-asserted-by":"crossref","unstructured":"Gies V , Schickel JN , Jung S , et al. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. JCI Insight 2018;3 doi: 10.1172\/jci.insight.96795.","DOI":"10.1172\/jci.insight.96795"},{"key":"2025090313095507000_6.2.e001258.79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13075-014-0477-1","article-title":"Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation","volume":"16","author":"Sieber","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025090313095507000_6.2.e001258.80","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00018-014-1806-x","article-title":"Syk is indispensable for CpG-induced activation and differentiation of human B cells","volume":"72","author":"Kremlitzka","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"2025090313095507000_6.2.e001258.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.03.014"},{"key":"2025090313095507000_6.2.e001258.82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12660","article-title":"Understanding B\u2212cell activation and autoantibody repertoire selection in systemic lupus erythematosus: a B\u2212cell immunomics approach","volume":"284","author":"Tipton","year":"2018","journal-title":"Immunol Rev"},{"key":"2025090313095507000_6.2.e001258.83","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T cell signaling and subsets in systemic lupus erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol"},{"key":"2025090313095507000_6.2.e001258.84","doi-asserted-by":"publisher","DOI":"10.1038\/nature14468"},{"key":"2025090313095507000_6.2.e001258.85","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/art.40038","article-title":"Signaling lymphocytic activation molecule family member 7 engagement restores defective effector CD8+ T cell function in systemic lupus erythematosus","volume":"69","author":"Comte","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/BOR.0000000000000576","article-title":"Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations","volume":"31","author":"Schrezenmeier","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2025090313095507000_6.2.e001258.87","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203040"},{"key":"2025090313095507000_6.2.e001258.88","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.169"},{"key":"2025090313095507000_6.2.e001258.89","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaf7153"},{"key":"2025090313095507000_6.2.e001258.90","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45790"},{"key":"2025090313095507000_6.2.e001258.91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700601"},{"key":"2025090313095507000_6.2.e001258.92","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaci.2016.01.035","article-title":"T-helper signals restore B\u2212cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity","volume":"138","author":"Szodoray","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025090313095507000_6.2.e001258.93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/eji.201646574","article-title":"B-cell activation with CD40L or CpG measures the function of B\u2212cell subsets and identifies specific defects in immunodeficient patients","volume":"47","author":"Marasco","year":"2017","journal-title":"Eur J Immunol"},{"key":"2025090313095507000_6.2.e001258.94","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150537"},{"key":"2025090313095507000_6.2.e001258.95","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2018.00665","article-title":"Putting on the brakes: regulatory kinases and phosphatases maintaining B cell anergy","volume":"9","author":"Franks","year":"2018","journal-title":"Front Immunol"},{"key":"2025090313095507000_6.2.e001258.96","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/art.39410","article-title":"Selective loss of signaling lymphocytic activation molecule family member 4-positive CD8+ T cells contributes to the decreased cytotoxic cell activity in systemic lupus erythematosus","volume":"68","author":"Kis-Toth","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2017.07.012","article-title":"The serine\/threonine protein phosphatase 2A controls autoimmunity","volume":"186","author":"Sharabi","year":"2018","journal-title":"Clin Immunol"},{"key":"2025090313095507000_6.2.e001258.98","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/eji.201747191","article-title":"Anti-interleukin-6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis","volume":"48","author":"Fleischer","year":"2018","journal-title":"Eur J Immunol"},{"key":"2025090313095507000_6.2.e001258.99","unstructured":"Isenberg D , et al, ACR 2019, Arthritis Rheumato 2019;7: suppl 10."},{"key":"2025090313095507000_6.2.e001258.100","unstructured":"Cohen S et al, EULAR 2019; OP0025."},{"key":"2025090313095507000_6.2.e001258.101","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1002\/art.38851","article-title":"Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"66","author":"Weinblatt","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.102","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25125"},{"key":"2025090313095507000_6.2.e001258.103","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N Engl J Med"},{"key":"2025090313095507000_6.2.e001258.104","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/art.39856","article-title":"Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double-blind, placebo-controlled trials","volume":"69","author":"Clowse","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313095507000_6.2.e001258.105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12079-016-0322-1","article-title":"Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor","volume":"10","author":"Lumb","year":"2016","journal-title":"J Cell Commun Signal"},{"key":"2025090313095507000_6.2.e001258.106","doi-asserted-by":"crossref","unstructured":"Huang W , Quach TD , Dascalu C , et al. Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients. JCI Insight 2018;3 doi: 10.1172\/jci.insight.122525.","DOI":"10.1172\/jci.insight.122525"},{"key":"2025090313095507000_6.2.e001258.107","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ebiom.2018.12.035","article-title":"B cell alterations during BAFF inhibition with belimumab in SLE","volume":"40","author":"Ramskold","year":"2019","journal-title":"EBioMedicine"},{"key":"2025090313095507000_6.2.e001258.108","doi-asserted-by":"publisher","DOI":"10.1002\/art.10856"},{"key":"2025090313095507000_6.2.e001258.109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200319301"},{"key":"2025090313095507000_6.2.e001258.110","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211388"},{"key":"2025090313095507000_6.2.e001258.111","doi-asserted-by":"crossref","unstructured":"Furie et al, EULAR 2019, FRI0195. Ann Rheum Dis 78 (Suppl 2):775.2\u2013776.","DOI":"10.1136\/annrheumdis-2019-eular.5529"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2020-001258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:10:12Z","timestamp":1756930212000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2020-001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":111,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,7,16]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/rmdopen-2020-001258"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2020-001258","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}